Abdominal aortic aneurysm histomorphology differs on the individual patient level and is not associated with classic risk factors, the HistAAA study

Maja Nackenhorst,Felix Menges,Bianca Bohmann,David Zschaepitz,Christine Bollwein,Sven Flemming,Nadja Sachs,Wolf Eilenberg,Christine Brostjan,christoph Neumayer,Matthias Trenner,Wiebke Ibing,Hubert Schelzig,Christian Reeps,Lars Maegdefessel,Heinz Regele,Markus Wagenhaeuser,Claus-Juergen Scholz,Thomas Christian Gasser,Albert Busch
DOI: https://doi.org/10.1101/2024.04.16.24305904
2024-05-17
Abstract:Objective: Abdominal aortic aneurysm (AAA) treatment is upon a diameter threshold by open (OAR) or endovascular aortic repair. So far, attempts for medical growth abrogation have failed. This study aims to elucidate the heterogeneity of AAA based on histomorphology in correlation to individual patient data and aneurysm metrics. Patients and Methods: Aneurysm samples from the left anterior wall from four university center biobanks underwent histologic analysis including angiogenesis, calcification, fibrosis, type and grade of inflammation in adventitia and media. Clinical information included age, comorbidities, etc., type of aneurysm (intact, symptomatic, ruptured, inflammatory) and growth. Aneurysm morphology included diameter and semi-automated geometric analysis using Endosize (Therenva) and finite element methods (A4Clinics Research Edition, Vacops GmbH). Results: 364 patient samples (85.4% male, median age 69 years) were evaluated and scored for acute (mixed/granulocytes) or chronic (mononuclear/plasma cells) inflammation, which was not associated with rupture (52x), symptomatic (37x; p = 0.51) or diameter (57 [52-69] mm; p = 0.87). The degree of fibrosis and the presence of angiogenesis were significantly higher (both p < 0.001) with increasing inflammation, which in turn significantly decreased with patient age (est = - 0.015/year, p = 0.017). No significant differences in were seen for ruptured (vs. intact), acute (vs. elective), male (vs. female) or diabetic patients. Current smoking was associated with chronic inflammation (p = 0.007) and a higher degree of fibrosis (p = 0.03). Aneurysm geometric morphology (n=252) or annual growth rate (n=142) were not associated with histologic characteristics. Yet, local luminal thrombus formation was significantly higher with increasing inflammation (p = 0.04). Conclusion: Type and degree of inflammation are the most distinguishable histologic characteristics in the AAA wall between individual patients, yet not associated with diameter or rupture. Local luminal thrombus formation is associated with inflammatory features and suggests a vivid bio-physical compartment with intra-individual differences.
What problem does this paper attempt to address?
The problem this paper attempts to address is the histopathological heterogeneity of Abdominal Aortic Aneurysm (AAA) among individual patients, and to explore the relationship between these heterogeneities and clinical characteristics, aneurysm morphology, and rupture risk. Specifically, the study conducted histological analysis on 364 AAA samples from a multicenter biobank, evaluating features such as inflammation type and degree, fibrosis extent, and neovascularization. The study found that the type and degree of inflammation varied significantly between individuals, but these inflammatory characteristics were not significantly associated with AAA diameter or rupture status. Additionally, older patients exhibited lower levels of inflammation. Smokers showed a higher tendency for fibrosis and chronic inflammation. The study also found that local intraluminal thrombus formation was significantly associated with inflammatory characteristics, suggesting that inflammatory activity may influence thrombus formation and its related biomechanical properties. In summary, this study aims to reveal the histological heterogeneity within the AAA wall and its relationship with individual patient data and aneurysm morphology, in order to provide new insights for understanding the mechanisms of AAA development and guiding clinical treatment.